Medical Editor: John P. Cunha, DO, FACOEP
HyperTET S/D Tetanus Immune Globulin (Human) is a vaccine indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain. HyperTET S/D is also indicated, although evidence of effectiveness is limited, in the regimen of treatment of active cases of tetanus. Common side effects of HyperTET include injection site soreness and fever.
The dose of HyperTET S/D for adults and children 7 years and older is 250 units given by deep intramuscular injection. The dose of HyperTET S/D for children less than 7 years old is based on the child's body weight. HyperTET may interact with live viral vaccines such as measles, mumps, polio, and rubella. Tell your doctor all medications and supplements you use and all vaccines you recently received. During pregnancy, HyperTET S/D should be administered only if prescribed; it is unknown if it would harm a fetus. Consult your doctor before breastfeeding.
Our HyperTET S/D Tetanus Immune Globulin (Human) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Slight soreness at the site of injection and slight temperature elevation may be noted at times. Sensitization to repeated injections of human immunoglobulin is extremely rare. In the course of routine injections of large numbers of persons with immunoglobulin there have been a few isolated occurrences of angio neurotic edema, nephrotic syndrome, and anaphylactic shock after injection.
Read the entire FDA prescribing information for HyperTET (Tetanus Immune Globulin (Human) Injection)
© HyperTET Patient Information is supplied by Cerner Multum, Inc. and HyperTET Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.